المؤلفون: Petrovic D; Department of Epidemiology and Health Systems (DESS), University Center for General Medicine and Public Health (UNISANTE), Lausanne, Switzerland; Department and Division of Primary Care Medicine, Geneva University Hospitals (HUG), Switzerland; Centre for Environment and Health, School of Public Health, Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom., Pruijm M; Department of Nephrology and Hypertension, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland., Ponte B; Department of Nephrology and Hypertension, Geneva University Hospitals (HUG), Switzerland., Dhayat NA; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Ackermann D; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Ehret G; Department of Cardiology, Geneva University Hospitals (HUG), Switzerland., Ansermot N; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Prilly, Switzerland., Vogt B; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Martin PY; Department of Nephrology and Hypertension, Geneva University Hospitals (HUG), Switzerland., Stringhini S; Department and Division of Primary Care Medicine, Geneva University Hospitals (HUG), Switzerland., Estoppey-Younès S; Department of Epidemiology and Health Systems (DESS), University Center for General Medicine and Public Health (UNISANTE), Lausanne, Switzerland., Thijs L; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Belgium., Zhang Z; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Belgium., Melgarejo JD; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Belgium., Eap CB; Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Prilly, Switzerland; School of Pharmaceutical Sciences, University of Geneva (UNIGE), Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva (UNIGE), Geneva, and University of Lausanne (UNIL), Lausanne, Switzerland., Staessen JA; Research Institute Alliance for Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium; Biomedical Sciences Group, Faculty of Medicine, University of Leuven, Leuven, Belgium., Bochud M; Department of Epidemiology and Health Systems (DESS), University Center for General Medicine and Public Health (UNISANTE), Lausanne, Switzerland. Electronic address: murielle.bochud@unisante.ch., Guessous I; Department and Division of Primary Care Medicine, Geneva University Hospitals (HUG), Switzerland. Electronic address: idris.guessous@hcuge.ch.

المصدر: Mayo Clinic proceedings [Mayo Clin Proc] 2021 Dec; Vol. 96 (12), pp. 3071-3085. Date of Electronic Publication: 2021 Sep 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: [Oxford, England] Country of Publication: England NLM ID: 0405543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-5546 (Electronic) Linking ISSN: 00256196 NLM ISO Abbreviation: Mayo Clin Proc Subsets: MEDLINE

مواضيع طبية MeSH: Caffeine/*adverse effects , Lipids/*blood, Adult ; Belgium ; Caffeine/blood ; Caffeine/metabolism ; Caffeine/urine ; Cholesterol/blood ; Cholesterol, HDL/blood ; Chromatography, High Pressure Liquid ; Female ; Humans ; Male ; Middle Aged ; Switzerland ; Tandem Mass Spectrometry ; Theobromine/adverse effects ; Theobromine/blood ; Theobromine/urine ; Theophylline/adverse effects ; Theophylline/blood ; Theophylline/urine ; Triglycerides/blood ; Xanthines/adverse effects ; Xanthines/blood ; Xanthines/urine

المؤلفون: Ponte B; Service of Nephrology, Department of Specialties, University Hospital of Geneva, Switzerland; Division of Chronic Diseases, Institute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Switzerland., Pruijm M; Service of Nephrology, University Hospital of Lausanne, Switzerland., Ackermann D; Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Switzerland., Ehret G; Department of Cardiology, University Hospital of Geneva, Switzerland., Ansermot N; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neurosciences, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Hospital of Cery, Prilly, Switzerland., Staessen JA; Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Belgium; Department of Epidemiology, Maastricht University, the Netherlands., Vogt B; Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Switzerland., Pechère-Bertschi A; Unit of Hypertension, Department of Community Medicine and Primary Care and Emergency Medicine, University Hospital of Geneva, Switzerland., Burnier M; Service of Nephrology, University Hospital of Lausanne, Switzerland., Martin PY; Service of Nephrology, Department of Specialties, University Hospital of Geneva, Switzerland., Eap CB; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neurosciences, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Hospital of Cery, Prilly, Switzerland; School of Pharmacy Geneva-Lausanne, Universities of Geneva and Lausanne, Switzerland., Bochud M; Division of Chronic Diseases, Institute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Switzerland., Guessous I; Unit of Population Epidemiology, Department of Community Medicine and Primary Care and Emergency Medicine, University Hospital of Geneva, Switzerland; Division of Chronic Diseases, Institute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Switzerland. Electronic address: idris.guessous@hcuge.ch.

المصدر: Mayo Clinic proceedings [Mayo Clin Proc] 2018 May; Vol. 93 (5), pp. 586-596. Date of Electronic Publication: 2018 Mar 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: [Oxford, England] Country of Publication: England NLM ID: 0405543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-5546 (Electronic) Linking ISSN: 00256196 NLM ISO Abbreviation: Mayo Clin Proc Subsets: MEDLINE

مواضيع طبية MeSH: Circadian Rhythm*/physiology , Vascular Stiffness*, Caffeine/*urine , Heart Ventricles/*metabolism, Adult ; Biomarkers/urine ; Blood Pressure ; Caffeine/metabolism ; Female ; Humans ; Male ; Middle Aged